Jason Fagone (Philadelphia Magazine)
FDA Drug Approvals: Congress Giveth then Taketh Away
Jeffrey Stein (The Chairman's Blog) Former TSRX CEO
Medical Product Activities During the Federal Government Shutdown
Food and Drug Administration (FDA) - official details / update posted 10/7
On the one year anniversary of implementation of the Prescription Drug User Fee Act (PDUFA V), what element has shown the most promise?
PhRMA - various commentators
Are $300K Drugs Disruptive To The Healthcare System?
John LaMattina (Forbes)
Rules for Biotech and Life Science Investing part 1
David Sable (And other secrets of the buy side blog)
The New Copycats: Engineering biosimilars, or near copies, of leading biologic drugs, pushes the limits of bioprocessing know-how
Ann Thayer (Chemical & Engineering News)